These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24021545)

  • 1. Granulomatosis with polyangiitis presenting as a renal mass successfully treated with rituximab.
    Lo Gullo A; Bajocchi G; Cassone G; Cavazza A; Zanichelli M; Salvarani C
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S138. PubMed ID: 24021545
    [No Abstract]   [Full Text] [Related]  

  • 2. Granulomatosis and polyangiitis: the rituximab option.
    Polachek A; Caspi D; Elkayam O
    Isr Med Assoc J; 2013 Mar; 15(3):193-4. PubMed ID: 23662388
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab seems a promising therapeutic option in granulomatosis with polyangiitis with intestinal perforation: a case report and literature review.
    Dag MS; Pehlivan Y; Tutar E; Kisacik B
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23345478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment with rituximab for a patient with p-ANCA glomerulonephritis, alveolar bleeding and multiple relapses during haemodialysis].
    Azancot MA; Agraz Pamplona I; Fort Ros J; Marín Valencia A; Gil Carballeira I; Camps Domenech J
    Nefrologia; 2010; 30(6):710-2. PubMed ID: 21113230
    [No Abstract]   [Full Text] [Related]  

  • 5. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.
    Eriksson P
    J Intern Med; 2005 Jun; 257(6):540-8. PubMed ID: 15910558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.
    Smith RM; Jones RB; Guerry MJ; Laurino S; Catapano F; Chaudhry A; Smith KG; Jayne DR
    Arthritis Rheum; 2012 Nov; 64(11):3760-9. PubMed ID: 22729997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal vasculitis in 2012: reclassification and the introduction of biologicals.
    Kallenberg CG
    Nat Rev Nephrol; 2013 Feb; 9(2):70-2. PubMed ID: 23296293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab as a new therapeutic option in granulomatosis with polyangiitis: a report of two cases.
    Dalkilic E; Alkis N; Kamali S
    Mod Rheumatol; 2012 Jun; 22(3):463-6. PubMed ID: 21847703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower doses of rituximab in remission induction for refractory granulomatosis with polyangiitis.
    Wawrzycka-Adamczyk K; Zugaj A; Włudarczyk A; Kosałka J; Sznajd J; Bazan-Socha S; Musiał J
    Przegl Lek; 2014; 71(12):663-5. PubMed ID: 25951692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center.
    Cartin-Ceba R; Golbin JM; Keogh KA; Peikert T; Sánchez-Menéndez M; Ytterberg SR; Fervenza FC; Specks U
    Arthritis Rheum; 2012 Nov; 64(11):3770-8. PubMed ID: 22730028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulomatosis With Polyangiitis in a Young Adult With Down Syndrome: Therapeutic Challenges and Clues to Immunopathogenesis.
    Mensah KA; Malek Pascha V; Moeckel G; Danve A
    J Clin Rheumatol; 2018 Apr; 24(3):153-156. PubMed ID: 29200025
    [No Abstract]   [Full Text] [Related]  

  • 12. Refractory Wegener's granulomatosis: effect of rituximab on granulomatous bilateral orbital involvement.
    Avshovich N; Boulman N; Slobodin G; Zeina AR; Rosner I; Rozenbaum M
    Isr Med Assoc J; 2009 Sep; 11(9):566-8. PubMed ID: 19960854
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
    Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
    Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell depleting agents for ANCA vasculitides: a new therapeutic approach.
    Gómez-Puerta JA; Quintana LF; Stone JH; Ramos-Casals M; Bosch X
    Autoimmun Rev; 2012 Jul; 11(9):646-52. PubMed ID: 22146313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Severe Wegener's granulomatosis successfully treated with rituximab].
    Semenkova EN; Krivosheev OG; Novikov PI; Osipenko VI; Nosova NR; Parfenova SA; Nikiforova NV; Borodin OO
    Ter Arkh; 2010; 82(6):53-5. PubMed ID: 20731113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experience with rituximab treatment (monoclonal antibodies to B-lymphocyte CD20 receptors) of Wegener's granulomatosis patients with renal impairment].
    Novikov PI; Krivosheev OG; Semenkova EN
    Ter Arkh; 2011; 83(11):70-6. PubMed ID: 22312891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wegener's intra-alveolar hemorrhage remission with rituximab.
    Baeza-Trinidad R; Rosel-Rioja L
    QJM; 2014 Sep; 107(9):773-4. PubMed ID: 24472733
    [No Abstract]   [Full Text] [Related]  

  • 19. Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the AutoImmunity and Rituximab Registry.
    Puéchal X; Gottenberg JE; Berthelot JM; Gossec L; Meyer O; Morel J; Wendling D; de Bandt M; Houvenagel E; Jamard B; Lequerré T; Morel G; Richette P; Sellam J; Guillevin L; Mariette X;
    Arthritis Care Res (Hoboken); 2012 Mar; 64(3):331-9. PubMed ID: 22076726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the management of systemic vasculitis: what did we learn in 2009?
    Hellmich B
    Clin Exp Rheumatol; 2010; 28(1 Suppl 57):98-103. PubMed ID: 20412713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.